[Federal Register Volume 70, Number 77 (Friday, April 22, 2005)]
[Notices]
[Pages 20933-20934]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-8087]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Inv. No. 337-TA-515]


In the Matter of Certain Injectable Implant Compositions; Notice 
of Commission Decision Not To Review an Initial Determination 
Terminating the Investigation in Its Entirety on the Basis of 
Withdrawal of the Complaint

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has determined not to review the presiding administrative 
law judge's (``ALJ'') initial determination (``ID'') terminating the 
above-captioned investigation as to all the respondents on the basis of 
withdrawal of the complaint.

FOR FURTHER INFORMATION CONTACT: Rodney Maze, Esq., Office of the 
General Counsel, U.S. International Trade Commission, 500 E Street, 
SW., Washington, DC 20436, telephone (202) 205-3065. Copies of non-
confidential documents filed in connection with this investigation are 
or will be available for inspection during official business hours 
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street, SW., Washington, DC 
20436, telephone (202) 205-2000. General information concerning the 
Commission may also be obtained by accessing its Internet server 
(http://www.usitc.gov). The public record for this investigation may be 
viewed on the Commission's electronic docket (EDIS) at http://

[[Page 20934]]

edis.usitc.gov. Hearing-impaired persons are advised that information 
on this matter can be obtained by contacting the Commission's TDD 
terminal on (202) 205-1810.

SUPPLEMENTARY INFORMATION: This patent-based section 337 investigation 
was instituted by the Commission based on a complaint filed by Inamed 
Corporation (``Inamed'') of Santa Barbara, California. 69 FR 35676 
(June 25, 2004). The complainant alleged violations of section 337 in 
the importation into the United States, the sale for importation, and 
the sale within the United States after importation of certain 
injectable implant compositions by reason of infringement of claims 1, 
2, 7, 12, 18, 20, 25, 26 and 30-34 of U.S. Patent No. 4,803,075. The 
complaint, as amended, named Q-Med Aktiebolag of Uppsala Sweden, 
Medicis Aesthetics, Inc., of Scottsdale, Arizona, and McKesson 
Corporation, McKesson Health Solutions of Arizona, Inc., and McKesson 
Supply Solutions, all of San Francisco, California, as respondents.
    On March 23, 2005, Inamed and the respondents filed a joint motion 
to terminate the investigation as to all parties based on withdrawal of 
the complaint. On April 4, 2005, the Commission investigative attorney 
filed a response in support of the motion. On April 5, 2005, the ALJ 
issued an ID (Order No. 33) granting the parties' joint motion for 
termination of the investigation. No petitions to review the ID were 
filed. The Commission has determined not to review this ID.

    Issued: April 18, 2005.

    By order of the Commission.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 05-8087 Filed 4-21-05; 8:45 am]
BILLING CODE 7020-02-P